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All detectable high-molecular-mass penicillin-binding proteins (HMM PBPs) are altered in a clinical isolate
of Streptococcus mitis for which the b-lactam MICs are increased from those previously reported in our region
(cefotaxime MIC, 64 mg/ml). These proteins were hardly detected at concentrations that saturate all PBPs in
clinical isolates and showed, after densitometric analysis, 50-fold-lower radiotracer binding. Resistance was
related to mosaic structure in all HMM PBP-coding genes, where critical region replacement was comple-
mented not only by substitutions already reported for the closely related Streptococcus pneumoniae but also by
other specific replacements that are presumably close to the active-site serine. Mosaic structure was also
presumed in a pbp1a-sensitive strain used for comparison, confirming that these structures do not unambig-
uously imply, by themselves, detectable critical changes in the kinetic properties of these proteins.
Although viridans streptococci are recognized as a common
cause of endocarditis (4, 9, 25) and are an increasingly re-
ported cause of bacteremia in neutropenic patients (2, 3, 5, 19,
25), the scientific community has lacked a clear delineation of
the pathogenic potential of individual species for viridans
streptococci, probably due to past and present difficulties in
their taxonomy and identification (7, 25, 45, 51, 52).
However, a rising incidence of b-lactam resistance in clinical
isolates of this group has often compromised patient survival
(4, 5, 8, 19, 30, 49), while occurrence of pneumococcal viru-
lence factor-encoding genes within them may imply that their
true pathogenic potential should be reevaluated (51).
Interspecies gene transfer of a variety of resistance markers
between different but closely related streptococcal species, all
of them naturally transformable and included in the mitis
group, is well documented (6, 10, 12, 13, 22). Frequently the
result of this interspecific recombination is mosaic genes, com-
posed of alternating blocks of nucleotides with different de-
grees of relatedness derived from a particular donor, which in
turn may have been affected by the same event. The recipient
may encode a protein with altered catalytic and/or immuno-
logical activity (21).
PBPs (penicillin-binding proteins), the b-lactam bacterial
targets, are ubiquitous enzymes involved in late steps of pep-
tidoglycan biosynthesis, a bacterium-specific pathway. These
proteins include the monofunctional DD-carboxypeptidases,
which are not essential for viability, low-molecular-mass PBPs,
and multidomain, generally essential, high-molecular-mass
(HMM) PBPs, in which a transmembrane spanner is linked to
a non-PB module, which in turn is linked to the amino end of
a PB module. It is assumed that all PBPs retain the same basic
tertiary structure in their PB module, with three conserved
motives forming the catalytic center: *SxxK, SxN, and KTG (x
denotes a variable amino acid residue). Each organism con-
tains a complete set of these enzymes, which are all targeted by
b-lactams. PBPs interact with the antibiotic by forming a rel-
atively stable, covalent complex via the active-site serine (15–
17).
b-Lactam resistance in clinically important viridans strepto-
cocci is mostly mediated by the presence of mosaic PBP genes
encoding altered PBPs with decreased affinity to antibiotics
(11, 12, 30). Higher concentrations of drugs are thus both
required to inhibit altered PBPs and to confer in vivo activity.
During 1994, a resistant strain (penicillin MIC, 16 mg/ml;
cefotaxime MIC, 64 mg/ml) tentatively identified as Streptococ-
cus mitis by biochemical methods, which formerly was misiden-
tified as Streptococcus pneumoniae, was isolated in an Argen-
tinian pediatric hospital. The misidentification was related to
phenotypic characteristics (colony morphology, Gram stain,
hemolytic pattern, and optochin sensitivity). Such resistance
levels had never been reported before for any member of the
mitis group in our area.
The aim of this work was to investigate and describe the
mechanism of resistance responsible for these high MICs.
All experiments were performed simultaneously with an-
other clinical isolate which was biochemically identical but
sensitive.
In order to solve any biochemical pitfall in the identification
of both isolates, a more reliable genetic identification was
attempted by sequencing the gene coding for 16S rRNA and
the manganese-dependent superoxide dismutase (sodA).
Their PBP pattern, relative affinity, and codifying genes, as
well as their deduced amino acid sequences, were analyzed.
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Comparative analysis of PBP amino acid sequences coming
from sensitive and resistant strains of S. mitis was done to
search for particular amino acid alterations present in resistant
strains of this species.
Although the participation of S. mitis in homologous recom-
bination events leading to mosaic genes in pneumococci is well
documented (11, 13, 22), reports of PBP patterns and PBP
genes of sensitive and resistant strains of S. mitis are still rare.
They are rare even when the appearance and spread of S. mitis
clinical isolates resistant to penicillin are a serious problem,
not only in areas where penicillin-resistant S. pneumoniae is
common but also in those with a low incidence of resistant
pneumococci (8, 19, 26, 30, 46).
(Part of this work was presented at the 100th General Meet-
ing of the American Society for Microbiology, Los Angeles,
Calif., May 2000.)
MATERIALS AND METHODS
Bacterial strains and growth conditions. Strains 127R and 209S were isolated
in close temporal proximity (3 months) in a pediatric hospital in Buenos Aires,
Argentina, during 1994 and were preliminarily identified by biochemical methods
as S. mitis. Identifications were confirmed by R. Facklam (Centers for Disease
Control and Prevention, Atlanta, Ga.). For most purposes both strains were
grown in brain heart infusion broth (Difco) at 37°C. The microorganisms were
kept frozen in 20% skim milk (Difco)–20% glycerol at 220, 270, and 2196°C
(the lowest temperature was for long-term storage). Escherichia coli INVaF9 and
E. coli TOP 10F9 (Invitrogen, Leek, The Netherlands) were used for cloning
experiments. SOC medium (1) was used during the cloning procedures.
Susceptibility tests. b-Lactam antibiotics were tested by the agar dilution
method on brain heart infusion agar (Difco) supplemented with 2.5% sheep
blood. Inocula were prepared by growing the strains overnight in liquid media
and diluting the cells 100-fold before plating. Incubation was performed at 37°C
for at least 48 h. Antibiotics were provided by various companies: penicillin G
(Eli Lilly Laboratorios, Buenos Aires, Argentina), dicloxacillin, oxacillin, and
cephaloridin (Sigma Chemical Co., St. Louis, Mo.), ampicillin (Laboratorios
Roemmers, Buenos Aires, Argentina), cefotaxime (Merck, Sharp and Dohme,
Buenos Aires, Argentina), cefuroxime and ceftazidime (Glaxo Wellcome,
Buenos Aires, Argentina), cephalotin (Roussel, Buenos Aires, Argentina), ceftri-
axone and cefalexin (Laboratorios Argentina, Buenos Aires, Argentina), ce-
foperazone (Pfizer, Buenos Aires, Argentina), and piperacillin and aztreonam
(Bristol-Myers, Buenos Aires, Argentina).
Sequencing of 16S rRNA coding and sodA genes. Chromosomal DNA was
obtained by conventional methods (43). fD1 and rD1 primers were used for
amplifying 16S rRNA genes (35, 50) in a Trio-thermoblock (Biometra thermo-
cycler). The reaction mixture (100 ml) contained 80 pmol of each primer and 2.5
mmol of each dNTP (Pharmacia Biotech, Uppsala, Sweden). PCR was per-
formed as follows: 5 min of denaturation at 95°C and 15 min of annealing at
50°C, with 2.5 U of Taq polymerase (Pharmacia Biotech) added 6 min after the
annealing temperature was reached. The reaction was followed by 30 cycles of
denaturation at 95°C for 1 min, annealing at 50°C for 2 min, and extension at
72°C for 2 min, concluding with a final extension for 20 min at 72°C. The DNA
fragments (1.5 kb) were purified with the Gene Clean purification kit (Bio 101,
La Jolla, Calif.), digested with EcoRI and BamHI (New England Bio Labs,
Beverly, Mass.), and cloned into digested pUC18.
An internal region of the sodA gene, coding for almost 85% of the manganese-
dependent superoxide dismutase, was amplified by PCR using degenerate prim-
ers (40) as described above but with the annealing temperature changed to 39°C.
The amplified 0.45-kb fragments were cloned into the PCR II vector (TA Clon-
ing kit; Invitrogen) following the manufacturer’s instructions.
DNA sequences were determined in at least two different clones using the
method described by Sanger et al. (44) in an Alf automatic sequencer (Pharmacia
Biotech).
Preparation of membranes. Cells of exponentially growing cultures were har-
vested by centrifugation and washed twice in 50 mM phosphate buffer (pH 7.0).
After resuspension in a minimum volume of the same buffer containing 50 mg of
DNase I (Sigma Chemical Co.)/ml, cells were disrupted by five passages through
a French press (SLM Instruments, Urbana, Ill.). The cell lysate was clarified by
centrifugation (10 min at 5,000 rpm; SS34 rotor in a Sorvall RC5 centrifuge), and
the clear supernatant was then centrifuged at 40,000 rpm for 50 min in a 50 Ti
rotor (Beckman RT ultracentrifuge). The pellet obtained was resuspended in a
minimum volume of 40 mM phosphate, 1 mM MgCl2, pH 7.0, and 5% glycerol
buffer and was conserved at 220°C until use. All steps were performed at 4°C.
Protein concentrations were determined by a modification of the method pio-
neered by Lowry (1).
Detection of PBPs. Membrane samples containing approximately 200 mg of
protein were labeled with the indicated concentrations of 125I-penicillin X (38)
and were incubated for 15 min at 37°C. The reaction was stopped by adding an
excess of nonradiolabeled antibiotic and by chilling on ice. Denaturing buffer
(0.25 M Tris-HCl, 8% sodium dodecyl sulfate, 20% b-mercaptoethanol, 0.008%
bromophenol blue, and 50% glycerol) was added, and the samples were imme-
diately boiled for 5 min and centrifuged for 2 min at 14,000 rpm (Bench Eppen-
dorf microcentrifuge).
Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis in 20-cm-long gels. The final acrylamide concentration of the sepa-
ration gel was 7% with an acrylamide/bisacrylamide ratio of 29.2:0.8. PBPs were
visualized after 10 days’ exposure at 220°C of an X-Omat Kodak film.
Amplification and sequencing of PBP genes.The genes homologous to pneu-
mococcal pbp2x and pbp2b from 127R and 209S were amplified with 2XUP and
2XDW primers (32) (corresponding to a region of the pneumococcal pbpX gene
including motives 2 to 7 of class B HMM PBPs) and with 2BUP and 2BDW
primers (14) (corresponding to a region coding for the transpeptidase domain).
The amplified DNA fragments were purified from agarose with the Gene Clean
II purification kit. Their ends were filled with T4 DNA polymerase. The frag-
ments were then phosphorylated with T4 DNA kinase (Pharmacia Biotech),
repurified, and cloned into SmaI/BAP pUC18 (Pharmacia Biotech). DNA se-
quences were determined in two clones, with oligonucleotides that primed at
intervals along each strand of the sequence.
Only a small portion of the gene homologous to pneumococcal pbp1a could be
amplified after several PCR attempts with published primers. A fragment of
0.8 kb could be obtained with primers 1AUp786 (59-CGGCATTCGATTTGAT
TCGCTTCT-39) (36) and 1A2Dw1598 (59-GGGTCATATTGGTTTGGTGC-39)
(37). Based on the known fragment sequence, the LA PCR cloning kit (Takara
Shuzo Co., Kyoto, Japan) was used following the manufacturer’s instructions.
Briefly, after preliminary previous hybridization experiments using the 0.8-kb
fragment as the probe, genomic DNA was completely digested with PstI and was
ligated with a PstI cassette (a double-stranded, synthetic oligonucleotide pro-
vided with the kit) and the corresponding PstI restriction site. A first PCR with
this ligation as DNA matrix was performed by using a cassette primer (provided
with the kit) and primer 1AS1 (59-CGAACTGATTGCTGACCTTGGATCTG
AAC-39), the design of which was based upon the known external region of 0.8
kb. A second PCR was performed after dilution of the first PCR product by using
a second inner cassette primer (provided) and primer 1AS2 (59-ACTTGGTCA
AGGCAATTGTGTCTATCGAAG-39), the design of which was based on the
inner 0.8 kb (an already-known region). A unique band of 2.4 kb was obtained,
cloned into pUC18, and sequenced as noted above.
Nucleotide sequence accession number. The EMBL database accession num-
bers for each gene are given for 127R and 209S, respectively: 16S rRNA gene,
AJ295848 and AJ295853; sodA, AJ295849 and AJ295854; pen2X, AJ295850 and
AJ295855; pen2b, AJ295851 and AJ295857; pen1a, AJ295852 and AJ295856.
RESULTS
Amplification and sequencing of the 16S rRNA gene. Single
bands of 1.5 kb were obtained for both strains. Their nucleo-
tide sequence had 99% identity with homologous genes of S.
mitis (GenBank accession no. D38482) (27), S. pneumoniae
(GenBank accession no. AF003930) (S. Emler, N. Liassine, J.
Pawlowsky, B. Hirschel, P. Rohner, and R. Auckenthaler, Ab-
str. 97th Gen. Meet. Am. Soc. Microbiol., abstr. D-155, p. 235,
1997), Streptococcus oralis (GenBank accession no. AF003932)
(Emler et al., Abstr. 97th Gen. Meet. Am. Soc. Microbiol.),
and Streptococcus sanguinis (GenBank accession no. AF
003928) (Emler et al., Abstr. 97th Gen. Meet. Am. Soc. Mi-
crobiol.). The sequences obtained from 127R and 209S differ
by only 2 nucleotides (99.94% of identity), clearly indicating
that both strains belong to the same species.
Amplification and sequencing of the sodA gene. Searching
for a more discriminative target sequence to differentiate our
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strains from closely related bacterial species, we amplified by
PCR an internal fragment of the sodA gene, obtaining a single
product of 0.45 kb. Nucleotide sequences from 127R and 209S
showed 97% identity with the homologous gene of S. mitis
NCTC 12261 (GenBank accession no. Z95909) (40) and 94%
identity with those of S. pneumoniae (GenBank accession no.
95914) (40) and S. oralis (GenBank accession no. Z99195)
(40). In all cases and for both strains, only 2 of 143 amino acids
changed in the analyzed fragment; showing 98% similarity to
the S. mitis protein, 97% similarity to the corresponding pneu-
mococcal protein, and 96% similarity to that of S. oralis. sodA
from S. sanguinis ATCC 10556 (GenBank accession no.
Z95918) (40) was 82% identical. Alignment of 127R and 209S
sequences revealed a 97% identity, pointing out that the sodA
heterogeneity was higher than in the 16S rRNA. Nevertheless,
this identity confirms that both strains belong to the same
bacterial species.
Antimicrobial susceptibility. MICs of the various b-lactams
tested, including early- and later-generation cephalosporins
(Table 1) showed high-level resistance in 127R, with values far
above those reported for this group of microorganisms. No
correlation between chemical structure and MICs could be
detected, suggesting that more than one PBP should be al-
tered.
This strain also showed, by agar diffusion tests, resistance to
erythromycin, rifampin, chloramphenicol, and trimetoprim-
sulfamethoxazole.
PBP pattern in sensitive and resistant strains. When PBPs
were labeled with 125I-penicillin at concentrations that usually
saturate PBPs of penicillin-resistant S. pneumoniae (23), three
HMM PBPs and one low-molecular-mass PBP could be de-
tected in both strains, but they did not show identical electro-
phoretic mobility (Fig. 1).
At a concentration that could saturate all the PBPs in the
sensitive strain (125I-penicillin X, 0.25 mg/ml), HMM PBPs in
the resistant strain were hardly visualized and showed, by
means of densitometry, an almost 50-fold-lower binding capac-
ity of the radiotracer (data not shown). Several PBPs are
present at the same positions in S. mitis NCTC 10712 and S.
pneumoniae R6 as well (30), but the relationship to these
proteins is not known.
HMM PBP genes in sensitive and resistant strains. The
unusually high resistance levels measured for strain 127R and
the fact that all the HMM PBPs of this strain showed a lower
affinity than did those of the sensitive strain suggested that
sequences of the PBP-encoding genes could give some insights
about changes probably responsible for sensitivity alterations.
Portions of the genes homologous to pbp2x and pbp2b of S.
pneumoniae could be amplified with primers designed accord-
ing to known sequences of penicillin-sensitive and -resistant
S. pneumoniae strains. In the case of the pbp1a homologous
genes, a different strategy was followed, as described in Mate-
rials and Methods.
pbp2x. In the resistant strain, this gene had a mosaic struc-
ture. When compared with the homologous gene of S. mitis
NCTC 10712 (the type strain for the species; sensitive) (46) the
C- and N-terminal coding portions (positions 1 to 400 and 1600
to 2000, respectively) showed 95% identity but diverged by
20% between positions 400 and 1000 and also between 1200
and 1600, with a short region of 90% identity between posi-
tions 1000 and 1200. Furthermore, the block between positions
540 and 780 had almost the same sequence as that of a peni-
cillin-resistant S. pneumoniae mutant (GenBank accession no.
X65132) (34), with 98% identity. At the C-terminal end en-
coding sequence, another 400-bp block, which started at posi-
tion 1620, was identical (99% identity) to that of a highly
TABLE 1. In vitro b-lactam antibiotic susceptibilities of strains
127R and 209Sa
Antibiotic
MIC (mg/ml) for strain:
127R 209S














a MICs were determined by the agar dilution method. ND, not determined.
FIG. 1. Radioactive detection of PBPs from strains 127R and 209S.
Membranes containing approximately 200 mg of proteins were labeled
with the indicated concentration of 125I-penicillin X and were incu-
bated for 15 min at 37°C. Penicillin concentrations are given in micro-
grams per milliliter.
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penicillin-resistant S. pneumoniae isolate (GenBank accession
no. U87092) (53). Another short sequence between positions
1260 and 1500 showed 98% identity with a penicillin-resistant
strain of S. mitis (GenBank accession no. Y10535) (42).
pbp2x from 209S was 91% identical to the homologous gene
of S. mitis NCTC 10712 (46) without any evidence of mosaic
structure
pbp2b. For this gene, the portion coding for the complete
C-terminal transpeptidase domain was amplified. In 127R it
also showed a mosaic structure. When compared to pbp2b of
S. mitis NCTC 10712 (13), only a small portion of the gene,
between positions 960 and 1260, showed 98% identity. The first
350-bp block diverged by 5% from that of the sensitive type
strain, and blocks from positions 350 to 960 and 1260 to 1500
differed by 17 and 21%, respectively. In addition, the first block
(positions 1 to 350) also showed similar percentages of identity
with those of several genes of penicillin-resistant clinical iso-
lates of S. pneumoniae (GenBank accession nos. U20076 and
U20074) (46) and of a recently described (22), highly cefo-
taxime-resistant clinical isolate of S. mitis (GenBank accession
no. AJ002289). Between positions 350 and 660 several homol-
ogous genes of penicillin-resistant S. pneumoniae strains
showed 94 to 96% identity. Two blocks of 300 bases (positions
660 to 960 and 1200 to 1500) showed no divergence with those
of penicillin-resistant isolates of S. pneumoniae (GenBank ac-
cession no. Z21981) (6) and S. oralis (GenBank accession no.
M32228) (11).
pbp2b from 209S is 94% identical to the homologous gene of
S. mitis NCTC 10712 (13), showing no evident mosaic struc-
ture.
pbp1a. For this gene, we encountered several difficulties in
the sequence analysis. First, the number of sequences available
in data banks was quite low compared to those for other PBP
genes, probably because PBP1A is not the primarily affected
b-lactam target in clinical isolates (18). Only a few sensitive
genes belonging to S. pneumoniae were available for compar-
ison. Furthermore, to our knowledge, only a portion of a highly
cefotaxime-resistant S. mitis was recently sequenced. However,
analysis of both sensitive and resistant genes strongly suggests
that intragenic recombination events may have occurred, since
polymorphism distribution was not at random. When com-
pared with homologous genes of S. pneumoniae, a very closely
related species, blocks with clearly different rates of divergence
could be detected in both resistant and sensitive genes as well.
Amino acid changes in resistant PBPs. The deduced amino
acid sequences were analyzed and aligned with homologous
sequences of sensitive and resistant S. mitis strains (Table 2).
Although changes already described to be involved in penicillin
and cefotaxime resistance in S. pneumoniae were also found in
127R, a few extra amino acid changes highlight new interesting
positions near the active site of the enzyme that are likely to
lead to changes in the affinity of the PBP (Fig. 2).
PBP2X. For this protein sequence, alignments from resistant
isolates of S. mitis showed that immediately after the active
S337, T338 was changed to P, A, or G. In S. pneumoniae these
changes reduced the acylation efficiency of the enzyme by
cefotaxime (39) (T to A) and by penicillins (T to P or G).
These changes were frequently found in clinical isolates with
unusually high levels of b-lactam resistance (33, 34). Accord-
ingly, strain 127R showed the T-to-P change, but strain 209S
possessed the same T residue as the type strain. Other resistant
S. mitis PBP2X analyzed also showed changes from T338 to P,
A, or G, but no correlation could be established with the
resistance level for any particular amino acid change. In all
resistant S. mitis strains, between the conserved SxxK and SxN
motives, I371 changed to T and downstream the conserved SxN
motif I398 replaced V, as observed in S. pneumoniae mutants
(33). In addition, we found substitutions at positions 510, 523,
531, 535, 538, and 574 in all resistant S. mitis strains, not
previously reported, which could point out interesting posi-
tions influencing the affinity of the PBP.
On the other hand, as opposed to changes described for
resistant pneumococci (22, 34, 46), positions 571 and 586 were
not changed in resistant strains of S. mitis.
PBP2B. In resistant S. mitis strains we found the T446-to-A
and A619-to-G changes described previously in penicillin-resis-
tant pneumococci and supposedly responsible for low-level
penicillin resistance, lower lysis rate, and piperacillin resistance
as well (18, 21, 24, 47). However, alignments showed additional
substitutions, which were present only in resistant S. mitis
strains. Upstream of the SxN motif, N421 was changed to Y and
Q426 to L. Downstream of the SxN motif, the following mod-
ifications were observed: S472 to T, S489 to A, I502 to V, N507 to
S, G594 to T, A596 to P, N605 to D, A608 to T, and finally, just
behind the KxG triad, A618 to G. In the C-terminal portion of
the protein, SD640 and NG659 were replaced by TE and KN,
respectively.
PBP1A. For this protein, the alignment includes only the
sequences obtained from 127R and 209S and a partial se-
quence belonging to a S. mitis clinical isolate, highly resistant
to cefotaxime, from Germany (22). Analyzing the PB domain
of PBP1A of the resistant strains, we found that at position
358, an I changed to T in the resistant strains. Several addi-
tional substitutions were also observed in the resistant strains:
V306 was changed to I, immediately after the active S370; T371
was changed to S, SIVH395 to YMLK; D405 to N and L425 to I;
N438 to E; V443 to D; N455 to D; SIH460 to TMV; Q475 to K;
E512 to S; A518 to Q; AY541 to YS; and finally, LP550 to IS 6
residues upstream of the KTG conserved motif. Part of the
amino acid changes is present in positions already described
for this and other PBPs in resistant pneumococci, but we also
detected other alterations in positions not previously de-
scribed.
TABLE 2. Strains used for PBP sequence alignmentsa
Accession no. S. mitisstrain Origin
Penicillin MIC
(mg/ml) Reference(s)
Y10535 Hu8 Hungary, 1990–92 6–12 22
Y10532 B5 Germany, 1994 8 22, 42
Y10533 197 Spain, 1990 16 42
Y10534 476 Spain, 1992 10 42
AJ002288 B6 Germany, 1994 50 22
AJ002289 B6 Germany, 1994 50 22
Z22183 11189 England, 1977 0.016 14
Z22231 NS51 Sweden, 1965 0.03 14
Z22186 K208 United States, 1932 0.03 14
a Figure 2 depicts alignments.
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The extensive and relatively rapid changes that have taken
place in the classification of the oral streptococci and the
increase in the number of species recognized in this group of
bacteria have not been accompanied by the development of
comprehensive species identification schemes for the ordinary
laboratory (28, 29, 45, 52). However, striking species-specific
variations in susceptibility, especially to b-lactams, are evident
from different studies (3, 19, 41, 49), suggesting that speciation
of oral streptococci must be warranted in order to evaluate
results reported by different studies. Up to date, no single
phenotypic or genotypic approach has demonstrated by itself
its universal usefulness (28, 29, 52). Intraspecies heterogeneity
and both lack of biochemical activity and genetic exchange
between different species have contributed to this scenario.
The identification of our strains could be achieved only when
biochemical and genetic results were taken together. Even
considered as a “gold standard” for several purposes, estab-
lishment of the complete coding sequence for the 16S rRNA
did not allow us to differentiate among S. mitis, S. sanguinis, S.
oralis, and S. pneumoniae species, since they showed 99% iden-
tity in this gene (they differ by only 10 to 12 nucleotides). We
concluded, thus, that the 16S rRNA sequence could not be
applied unambiguously to the identification of this group of
microorganisms.
Analysis of partial sequence of sodA has been proposed as a
reliable and accurate method for members of the mitis group
(28, 40). Kawamura et al. indicated that the evolutionary rate
of the sodA partial gene was much higher than that of the 16S
rRNA gene and that the sodA partial sequencing would be
useful for differentiating closely genetically related organisms
(28). In our case, sequences indicated that a higher interspe-
cies heterogeneity than in the 16S rRNA could exist in this
gene, but the identity with S. pneumoniae and S. oralis re-
mained high (up to 95%).
The difficulties encountered for the identification of our
strains could be due, in part, to the genetic exchanges that they
have undergone. Further efforts should be made to improve
the available methods or to find new powerful approaches in
order to identify oral streptococci and particularly those of the
mitis group, which, because of genetic exchange, seem to con-
stitute a complex mosaic group more than clearly separated
entities (12, 45). When studying an isolate of this group of
organisms, and before defining the species, all available bio-
chemical and genetic features must be examined and analyzed
as a whole.
The b-lactam MICs determined for strain 127R are ex-
tremely high for this group of microorganisms, which are usu-
ally susceptible to penicillin concentrations as low as a few
nanograms per milliliter. Such MICs, at least in pneumococci,
could only be reached when more than one b-lactam target is
altered (21, 22, 24). In the resistant strain all the HMM PBPs
(detected with a radiotracer with a high specific activity)
showed a much lower binding of the radioactive antibiotic than
did those of the sensitive strain, indicating that they all had a
reduced affinity for penicillin. Precompetition with other non-
FIG. 2. Protein sequence alignments from sensitive and resistant strains of S. mitis. All amino acid sequences belong to different strains of S.
mitis and are named under their accession number (GenBank). 127R results are from this study. Shown in boldface are conserved motifs and
selected amino acid positions where we detected variation along the complete protein sequence of sensitive strains 209S (this study) and S. mitis
NCTC 10712 (there were no amino acid differences between them). R, b-lactam-resistant strain; S, b-lactam-sensitive strain; pp, changes not
previously reported in pneumococci; #, changes found only in strain 127R. The indicated numbers correspond to positions in PBPs from S.
pneumoniae R6.
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radioactive b-lactam antibiotics and postlabeling assays (data
not shown) confirmed the observation that a reduced affinity
existed in all the HMM PBPs of strain 127R. Since all of the
b-lactam targets had altered affinity, higher concentrations of
drugs are thus required to inhibit these enzymes.
In 127R the sequences of the HMM PBP-encoding genes
display a mosaic structure, with blocks diverging up to 20%
from the sensitive homologous genes.
However, this feature does not seem to be restricted to the
resistant phenotype: a mosaic structure could be inferred when
analyzing pbp1a from the sensitive strain 209S. Sibold et al. and
Dowson et al. described this phenomenon earlier in PBP2B
genes of penicillin-sensitive S. mitis (13, 46), as did Spratt et al.
for penicillin-sensitive isolates of Neisseria lactamica and Neis-
seria polisaccharea (48), but mosaic genes, even coding for
primarily affected b-lactam targets, have no selective advan-
tage for penicillin resistance. The observation that, in pneu-
mococci, mosaic genes are found only in penicillin-resistant
isolates but not in penicillin-sensitive strains (24) seems not to
be the case for S. mitis. In this species, genes displaying mosaic
structures do not unequivocally code for proteins with detect-
able reduced affinity, and the same could be true also for
pneumococci, considering that most of the analyzed PBP genes
come from resistant strains. Nevertheless, PBP1A is not a
primarily affected target in resistant pneumococci (18, 31), as it
presumably is in the mitis group. Consequently, it can be ex-
pected that alterations in kinetic properties in this protein, if
present, should not be by themselves responsible for changes in
susceptibility.
With those results, we assume that precise amino acid
changes should simultaneously be present along with a mosaic
structure, at least in primarily affected b-lactam targets (PBP2B
and PBP2X), to yield highly resistant isolates. Protein se-
quence alignments showed that the amino acid changes found
in resistant isolates are not present in sensitive strains, so both
mosaic structures and amino acid changes seem to be indis-
pensable for b-lactam resistance in the viridans streptococci.
Furthermore, the amino acid changes that we found after
protein alignment occur at positions common to all the ana-
lyzed PBPs. A few additional substitutions are seen in all re-
sistant strains. They were not reported before in the closely
related pneumococci; perhaps they could be pointing out in-
teresting positions leading to reduced affinity of each PBP.
Most of these modifications are probably responsible for in-
creasing MICs. Those for example in the vicinity of the cavity
forming the active site of the PBPs could be important for the
interaction of the antibiotic with the enzyme. More informa-
tion about the three-dimensional structure of these proteins is
needed to validate these observations.
Further studies should be encouraged to enlarge our knowl-
edge about particular resistance mechanisms in this species,
since reports of resistant isolates are rapidly increasing. Per-
haps most important is the fact that these resistant strains
constitute a potential pool of genes for the development of
high-level b-lactam resistance in S. pneumoniae strains and
other pathogens of the mitis group, in which genetic compe-
tence has provided a powerful tool for the uptake and incor-
poration of resistance determinants.
ACKNOWLEDGMENTS
We are grateful to Horacio Lopardo (Hosp. Nac. de Pediatrı´a) and
to P. Garrahan and Marta Altschuler (Hosp. Sor Marı´a Ludovica,
Buenos Aires, Argentina) for providing clinical isolates; to Carlos Vay
for helpful discussion related to bacterial identification; and to Richard
Facklam, Centers for Disease Control and Prevention, Atlanta, Ga.,
for biochemical identification of strains. We thank Iris Thamm for
technical support with automated DNA sequencing.
This work was supported in part by grants from the University of
Buenos Aires, (Buenos Aires, Argentina) (TB 039) and from the
CONICET (PID 4413) to G.G. and in part by the Belgian Programme
on Interuniversity Poles of Attraction initiated by the Belgian govern-
ment, Prime Minister’s Office, Services fe´de´raux des affaires scienti-
fiques, techniques et culturelles (PAI P4/03). A.A. was a recipient of a
fellowship from the European Community, Program ALFA, Project
5.0111.9. G.G. is a member of the “Carrera de Investigador Cientı´-
fico,” CONICET, Buenos Aires, Argentina.
REFERENCES
1. Ausubel, F., R. Brent, R. Kingston, D. Moore, J. Seidman, J. Smith, and J.
Struhl (ed.). 1990. Current protocols in molecular biology. Greene Publish-
ing Associates and Wiley Interscience, New York, N.Y.
2. Avada, A., P. van der Auwera, F. Meunier, D. Daneau, and J. Klastersky.
1992. Streptococcal and enterococcal bacteremia in patients with cancer.
Clin. Infect. Dis. 15:33–48.
3. Bochud, P. Y., P. Engiman, T. Calandra, G. van Melle, L. Saghafi, and P.
Francioli. 1994. Bacteremia due to viridans streptococci in neutropenic pa-
tients with cancer: clinical spectrum and risk factors. Clin. Infect. Dis. 18:
25–31.
4. Bouvet, A., A. Durand, C. Devine, J. Etienne, and C. Leport. 1994. In vitro
susceptibility to antibiotics of 200 strains of streptococci and enterococci
isolated during infective endocarditis, p. 72–73. In A. Totolian (ed.), Patho-
genic streptococci: present and future. Lancer Publications, St. Petersburg,
Russia.
5. Carratala, J., F. Alcaide, A. Fernandez-Sevilla, X. Corbella, J. Lin˜ares, and
F. Gudiol. 1995. Bacteremia due to viridans streptococci that are highly
resistant to penicillin: increase among neutropenic patients with cancer. Clin.
Infect. Dis. 20:1169–1173.
6. Coffey, T. J., C. G. Dowson, M. Daniels, and B. G. Spratt. 1993. Horizontal
spread of an altered penicillin-binding protein 2B gene between Streptococ-
cus pneumoniae and Streptococcus oralis. FEMS Microbiol. Lett. 110:335–
339.
7. Coykendall, A. 1989. Classification and identification of the viridans strep-
tococci. Clin. Microbiol. Rev. 2:315–328.
8. Doern, G., M. Ferraro, A. Brueggemann, and K. Ruoff. 1996. Emergence of
high rates of antimicrobial resistance among viridans group streptococci in
the United States. Antimicrob. Agents Chemother. 40:891–894.
9. Douglas, C. W. I., J. Heath, K. K. Hampton, and F. E. Preston. 1993. Identity
of viridans streptococci isolated from cases of infective endocarditis. J. Med.
Microbiol. 39:179–182.
10. Dowson, C., A. Hutchison, J. Brannigan, R. George, D. Hansman, J. Lin˜ares,
A. Tomasz, J. Smith, and B. Spratt. 1989. Horizonal transfer of penicillin-
binding protein genes in penicillin-resistant clinical isolates of Streptococcus
pneumoniae. Proc. Natl. Acad. Sci. USA 86:8842–8846.
11. Dowson, C., A. Hutchison, N. Woodford, A. Johnson, R. George, and B.
Spratt. 1990. Penicillin resistant viridans streptococci have obtained altered
penicillin-binding protein genes from penicillin-resistant strains of Strepto-
coccus pneumoniae. Proc. Natl. Acad. Sci. USA 87:5858–5862.
12. Dowson, C., V. Barcus, S. King, P. Pickerill, A. Whatmore, and M. Yeo. 1997.
Horizontal gene transfer and the evolution of resistance and virulence de-
terminants in Streptococcus. J. Appl. Microbiol. Symp. Ser. 83:42S–51S.
13. Dowson, C., T. Coffey, C. Kell, and R. Whiley. 1993. Evolution of penicillin
resistance in Streptococcus pneumoniae: the role of Streptococcus mitis in the
formation of a low affinity PBP 2B in Streptococcus pneumoniae. Mol. Mi-
crobiol. 9:635–643.
14. Dowson, C., A. Hutchison, and B. Spratt. 1989. Extensive remodelling of the
transpeptidase domain of penicillin binding protein 2B of a penicillin resis-
tant South African isolate of Streptococcus pneumoniae. Mol. Microbiol.
3:95–102.
15. Ghuysen, J. M. 1997. Penicillin binding proteins, wall peptidoglycan assem-
bly and resistance to penicillin: facts, doubts and hopes. Int. J. Antimicrob.
Agents 8:45–60.
16. Ghuysen, J. M., P. Charlier, J. Coyette, C. Duez, E. Fonze´, C. Fraipont, C.
Goffin, B. Joris, and M. Nguyen-Diste`che. 1996. Penicillin and beyond:
protein fold, multimodular polypeptides and multiprotein complexes. Mi-
crob. Drug Resist. 2:163–175.
17. Goffin, C., and J. M. Ghuysen. 1998. The multimodular penicillin-binding
proteins: an enigmatic family of orthologs and paralogs. Microbiol. Mol.
Biol. Rev. 62:1079–1093.
2080 AMOROSO ET AL. ANTIMICROB. AGENTS CHEMOTHER.
 o
n








18. Grebe, T., and R. Hakenbeck. 1996. Penicillin-binding proteins 2b and 2x of
Streptococcus pneumoniae are primary resistance determinants for different
classes of b-lactam antibiotics. Antimicrob. Agents Chemother. 40:829–834.
19. Guiot, H. F. L., L. J. K. Corel, and J. M. J. J. Vossen. 1994. Prevalence of
penicillin-resistant viridans streptococci in healthy children and in patients
with malignant haematological disorders. Eur. J. Clin. Microbiol. Infect. Dis.
13:645–650.
20. Hakenbeck, R. 1995. Target-mediated resistance to b-lactam antibiotics.
Biochem. Pharmacol. 50:1121–1127.
21. Hakenbeck, R. 1998. Mosaic genes and their role in penicillin-resistant Strep-
tococcus pneumoniae. Electrophoresis 19:597–601.
22. Hakenbeck, R., A. Ko¨nig, I. Kern, M. van der Linden, W. Keck, D. Billot-
Klein, R. Legrand, B. Schoot, and L. Gutmann. 1998. Acquisition of five
high-Mr penicillin-binding protein variants during transfer of high-level
b-lactam resistance from Streptococcus mitis to Streptococcus pneumoniae. J.
Bacteriol. 180:1831–1840.
23. Hakenbeck, R., C. Martin, C. Dowson, and T. Grebe. 1994. Penicillin-binding
protein 2b of Streptococcus pneumoniae in piperacillin-resistant laboratory
mutants. J. Bacteriol. 176:5574–5577.
24. Hakenbeck, R., T. Grebe, D. Za¨hner, and J. Stock. 1999. b-Lactam resistance
in Streptococcus pneumoniae: penicillin-binding proteins and non-penicillin-
binding proteins. Mol. Microbiol. 33:673–678.
25. Hardie, J., and R. Whiley. 1994. Recent developments in streptococcal tax-
onomy: their relation to infections. Rev. Med. Microbiol. 3:151–162.
26. Jacobs, J., H. Schouten, E. Stobberingh, and P. Soeters. 1995. Viridans
streptococci isolated from the bloodstream. Diagn. Microbiol. Infect. Dis.
22:267–273.
27. Kawamura, Y., X. G. Hou, F. Sultana, H. Miura, and T. Ezaki. 1995. De-
termination of 16S rRNA sequences of Streptococcus mitis and Streptococcus
gordonii and phylogenetic relationships among members of genus Strepto-
coccus. Int. J. Syst. Bacteriol. 45:406–408.
28. Kawamura, Y., R. Whiley, S. Shu, T. Ezaki, and J. Hardie. 1999. Genetic
approaches to the identification of the mitis group within the genus Strep-
tococcus. Microbiology 145:2605–2613.
29. Kikuchi, K., T. Ezaki, K.-I. Totsuka, and K. Shimizu. 1995. Comparison of
phenotypic characteristics, DNA-DNA hybridization results, and results with
a commercial rapid biochemical and enzymatic reaction system for identifi-
cation of viridans group streptococci. J. Clin. Microbiol. 33:1215–1222.
30. Ko¨nig, A., R. Reinert, and R. Hakenbeck. 1998. Streptococcus mitis with
unusually high-level resistance to b-lactam antibiotics. Microb. Drug Resist.
4:45–49.
31. Kraub, J., M. van der Linden, T. Grebe, and R. Hakenbeck. 1996. Penicillin-
binding proteins 2x and 2b as primary PBP targets in Streptococcus pneu-
moniae. Microb. Drug Resist. 2:183–186.
32. Laible, G., R. Hakenbeck, M. A. Sicard, B. Joris, and J. M. Ghuysen. 1989.
Nucleotide sequence of the pbpX gene encoding the penicillin-binding pro-
tein 2X from Streptococcus pneumoniae R6 and a cefotaxime-resistant mu-
tant, C506. Mol. Microbiol. 3:1337–1348.
33. Laible, G., and R. Hackenbeck. 1991. Five independent combinations of
mutations can result in low-affinity penicillin-binding protein 2x of Strepto-
coccus pneumoniae. J. Bacteriol. 173:6986–6990.
34. Laible, G., B. G. Spratt, and R. Hakenbeck. 1991. Interspecies recombina-
tional events during the evolution of altered PBP 2x genes in penicillin-
resistant clinical isolates of Streptococcus pneumoniae. Mol. Microbiol.
5:1993–2002.
35. Lane, D., B. Pace, G. Olsen, D. Stahl, M. Sogin, and N. Pace. 1985. Rapid
determination of 16S ribosomal RNA segments for phylogenetic analyses.
Proc. Natl. Acad. Sci. USA 82:6955–6959.
36. Martin, C., T. R. Briese, and R. Hakenbeck. 1992. Nucleotide sequences of
genes encoding penicillin-binding proteins from Streptococcus pneumoniae
and Streptococcus oralis with high homology to Escherichia coli penicillin-
binding proteins 1A and 2B. J. Bacteriol. 174:4517–4523.
37. Martin, C., C. Sibold, and R. Hakenbeck. 1992. Relatedness of penicillin-
binding protein 1A genes from different clones of penicillin-resistant Strep-
tococcus pneumoniae isolated in South Africa and Spain. EMBO J. 11:3831–
3836.
38. Masson, J. M., and R. Labia. 1983. Synthesis of a 125I-radiolabeled penicillin
for penicillin-binding protein studies. Anal. Biochem. 128:164–168.
39. Mouz, N., E. Gordon, A. M. Di Guilmi, I. Petit, Y. Petillot, Y. Dupont, R.
Hakenbeck, T. Vernet, and O. Dideberg. 1998. Identification of a structural
determinant for resistance to b-lactam antibiotics in Gram-positive bacteria.
Proc. Natl. Acad. Sci. USA 95:13403–13406.
40. Poyart, C., G. Quesne, S. Caelon, P. Berche, and P. Trieu-Cuot. 1998.
Identification of streptococci to species levels by sequencing the gene en-
coding the manganese-dependent superoxide dismutase. J. Clin Microbiol.
36:41–47.
41. Quinn, J. P., C. Di Vicenzo, D. Lucks, R. Luskin, K. Shatzer, and S. Lerner.
1988. Serious infections due to penicillin-resistant strains of viridans strep-
tococci with altered penicillin-binding proteins. J. Infect. Dis. 157:764–769.
42. Reichmann, P., A. Ko¨nig, J. Lin˜ares, F. Alcaide, F. Tenover, L. McDugal, S.
Swidsinski, and R. Hakenbeck. 1997. A global gene pool for high-level
cephalosporin resistance in commensal Streptococcus species and Streptococ-
cus pneumoniae. J. Infect. Dis. 176:1001–1012.
43. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a
laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, N.Y.
44. Sanger, I., S. Nicklen, and A. Coulson. 1977. DNA sequencing with chain-
terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463–5467.
45. Schlegel, L., and A. Bouvet. 1998. Streptocoques et genres apparente´s: abio-
trophes et enterocoques. Bull. Soc. Fr. Microbiol. 13:7–17.
46. Sibold, C., J. Henrichsen, A. Ko¨nig, C. Martin, L. Chalkley, and R. Haken-
beck. 1994. Mosaic pbpX genes of major clones of penicillin-resistant Strep-
tococcus pneumoniae have evolved from pbpX genes of a penicillin-sensitive
Streptococcus oralis. Mol. Microbiol. 12:1013–1023.
47. Smith, A. M., and K. P. Klugman. 1995. Alterations in penicillin-binding
protein 2B from penicillin-resistant wild-type strains of Streptococcus pneu-
moniae. Antimicrob. Agents Chemother. 39:859–867.
48. Spratt, B. G., L. D. Bowler, Q.-Y. Zhang, J. Zhou, and J. M. Smith. 1992.
Role of interspecies transfer of chromosomal genes in the evolution of
penicillin resistance in pathogenic and commensal Neisseria species. J. Mol.
Evol. 34:115–125.
49. Tuohy, M., and J. Washington. 1997. Antimicrobial susceptibility of viridans
group streptococci. Diagn. Microbiol. Infect. Dis. 29:277–280.
50. Weisburg, W., S. Barns, D. Pelletier, and D. Lane. 1991. 16S ribosomal DNA
amplification for phylogenetic study. J. Bacteriol. 173:697–703.
51. Whatmore, A. M., A. Efstratiou, A. P. Pickerill, K. Broughton, G. Woodward,
D. Sturgeon, R. George, and C. G. Dowson. 2000. Genetic relationships
between clinical isolates of Streptococcus pneumoniae, Streptococcus oralis,
and Streptococcus mitis: characterization of “atypical” pneumococci and or-
ganisms allied to S. mitis harboring S. pneumoniae virulence factor-encoding
genes. Infect. Immun. 68:1374–1382.
52. Whiley, R. A., and D. Beighton. 1998. Current classification of the oral
streptococci. Oral Microbiol. Immunol. 13:195–216.
53. Zhao, G., W.-K. Yeh, R. H. Carnahan, J. Flokowitsch, T. I. Meier, W. E.
Alborn, Jr., G. W. Becker, and S. R. Jaskunas. 1997. Biochemical charac-
terization of penicillin-resistant and -sensitive penicillin-binding protein 2x
transpeptidase activities of Streptococcus pneumoniae and mechanistic im-
plications in bacterial resistance to b-lactam antibiotics. J. Bacteriol. 179:
4901–4908.
VOL. 45, 2001 b-LACTAM RESISTANCE IN S. MITIS 2081
 o
n
 February 29, 2016 by UNIV DE LIEG
E
http://aac.asm
.org/
D
ow
nloaded from
 
